| Linn M Mangano, MD | |
|
3333 Burnet Avenue, Ml 4008, Cincinnati, OH 45229-3026 | |
| (513) 636-4751 | |
| (513) 636-7911 |
| Full Name | Linn M Mangano |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 36 Years |
| Location | 3333 Burnet Avenue, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346241403 | NPI | - | NPPES |
| 0095982000 | Medicaid | WV | |
| P00354867 | Other | WV | RAILROAD MEDICARE |
| 200099910 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | TP004 (Kentucky) | Secondary |
| 207W00000X | Ophthalmology | 35.067259 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summa Health System | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summa Physicians Inc | 2961303532 | 640 |
News Archive
Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.
American Academy of Dermatology Association (AADA) President and dermatologist William D. James, MD, FAAD, along with other dermatologists and leading researchers today testified before a Food and Drug Administration (FDA) panel considering changes to the current classification of indoor tanning devices. Currently, the FDA classifies indoor tanning devices as Class 1, the category for items that have minimal potential to cause harm to individuals. Items in Class 1 include adhesive bandages and tongue depressors.
The New York Times: "Fearing that health insurance premiums may shoot up in the next few years, Senate Democrats laid a foundation on Tuesday for federal regulation of rates, four weeks after President Obama signed a law intended to rein in soaring health costs." Sen. Dianne Feinstein, D-Calif., introduced legislation that would allow the federal health secretary to block "any rate increase found to be unreasonable," an authority that would be shared with some state insurance officials.
An increased incidence of peanut allergy in children from more wealthy families supports the "hygiene hypothesis" that overcleanliness may promote the onset of childhood allergies, say US researchers.
Stem cells have long been touted as the next big thing. Well just maybe, it is here. According to Dr. Dennis Lox, some patients with a disorder of the bone called avascular necrosis (AVN), have turned to stem cell therapy for aid.
› Verified 1 days ago
| Entity Name | Summa Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235167719 PECOS PAC ID: 2961303532 Enrollment ID: O20040116000295 |
News Archive
Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.
American Academy of Dermatology Association (AADA) President and dermatologist William D. James, MD, FAAD, along with other dermatologists and leading researchers today testified before a Food and Drug Administration (FDA) panel considering changes to the current classification of indoor tanning devices. Currently, the FDA classifies indoor tanning devices as Class 1, the category for items that have minimal potential to cause harm to individuals. Items in Class 1 include adhesive bandages and tongue depressors.
The New York Times: "Fearing that health insurance premiums may shoot up in the next few years, Senate Democrats laid a foundation on Tuesday for federal regulation of rates, four weeks after President Obama signed a law intended to rein in soaring health costs." Sen. Dianne Feinstein, D-Calif., introduced legislation that would allow the federal health secretary to block "any rate increase found to be unreasonable," an authority that would be shared with some state insurance officials.
An increased incidence of peanut allergy in children from more wealthy families supports the "hygiene hypothesis" that overcleanliness may promote the onset of childhood allergies, say US researchers.
Stem cells have long been touted as the next big thing. Well just maybe, it is here. According to Dr. Dennis Lox, some patients with a disorder of the bone called avascular necrosis (AVN), have turned to stem cell therapy for aid.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Linn M Mangano, MD 3333 Burnet Avenue, Ml 4008, Cincinnati, OH 45229-3026 Ph: (513) 636-4751 | Linn M Mangano, MD 3333 Burnet Avenue, Ml 4008, Cincinnati, OH 45229-3026 Ph: (513) 636-4751 |
News Archive
Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.
American Academy of Dermatology Association (AADA) President and dermatologist William D. James, MD, FAAD, along with other dermatologists and leading researchers today testified before a Food and Drug Administration (FDA) panel considering changes to the current classification of indoor tanning devices. Currently, the FDA classifies indoor tanning devices as Class 1, the category for items that have minimal potential to cause harm to individuals. Items in Class 1 include adhesive bandages and tongue depressors.
The New York Times: "Fearing that health insurance premiums may shoot up in the next few years, Senate Democrats laid a foundation on Tuesday for federal regulation of rates, four weeks after President Obama signed a law intended to rein in soaring health costs." Sen. Dianne Feinstein, D-Calif., introduced legislation that would allow the federal health secretary to block "any rate increase found to be unreasonable," an authority that would be shared with some state insurance officials.
An increased incidence of peanut allergy in children from more wealthy families supports the "hygiene hypothesis" that overcleanliness may promote the onset of childhood allergies, say US researchers.
Stem cells have long been touted as the next big thing. Well just maybe, it is here. According to Dr. Dennis Lox, some patients with a disorder of the bone called avascular necrosis (AVN), have turned to stem cell therapy for aid.
› Verified 1 days ago
Mr. Jeffrey A Nerad, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1945 Cei Drive, Cincinnati Eye Institute, Cincinnati, OH 45242 Phone: 513-984-5133 Fax: 513-569-3941 | |
Wendy Anandajeya Kirkland, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2139 Auburn Ave, Cincinnati, OH 45219 Phone: 513-585-0855 Fax: 513-585-2673 | |
Dr. Gary A Varley, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1945 Cei Drive, Cincinnati, OH 45242 Phone: 513-984-5133 Fax: 513-569-3941 | |
Faizuddin Khaja, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2055 Reading Rd, Suite 330, Cincinnati, OH 45202 Phone: 513-381-1900 Fax: 513-287-6403 | |
Dr. Mary Eileen Grulee, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 8040 Hosbrook Rd, Suite 100, Cincinnati, OH 45236 Phone: 513-891-0473 Fax: 513-891-0543 | |
Robert A Sisk, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1945 Cei Dr, Cincinnati, OH 45242 Phone: 513-569-3741 Fax: 513-569-3941 | |
Dr. William Michael Gaynier, D.O Ophthalmology Medicare: Medicare Enrolled Practice Location: 3130 Highland Ave, Cincinnati, OH 45219 Phone: 513-584-5461 Fax: 513-584-0828 |